Supercede
InsurTech · Reinsurance
Sponsors visas
5EmployeesUK accounts · Feb 2026 · +25% in a year
Facts
as of Nov 17, 2026Supercede is the leading reinsurtech platform, streamlining reinsurance with advanced data management and deal-making tools for superior outcomes.
- Legal name
- SUPERCEDE LTDactive
- Headquarters
- Cleckheaton, United Kingdom
- Founded
- 2019
- Employees
- 5UK accounts · Feb 2026 · +25% in a year
- Register numbers
- CRN 11805154
- Official records
- Companies House 11805154
- Website
- supercede.com
These are the key facts about Supercede on Alion as of Nov 17, 2026. Supercede is headquartered in Cleckheaton, United Kingdom. It was founded in 2019.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
SUPERCEDE LTD
Yes
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Visa
Full chapter →Named in the work visa registers of United Kingdom.
A-ratedSponsor licence
Skilled WorkerVisa route
0Open roles in United Kingdom
In the register as SUPERCEDE LTD, Cleckheaton, WEST YORKSHIRE
Other sponsors in the same field
Alert me
UK Home Office · checked Nov 17, 2026
Footprint
Hiring in 2 cities in 1 country.
2Cities
1Countries
Loading the map
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Cleckheaton United Kingdom | Headquarters | 0 | ||
| London United Kingdom | Regional office | 0 |
Source: office addresses in postings and company registers
Milestones
Feb 4, 2019
Founded per the company register
Each milestone is dated by its source: registers, filings, the press
Newsroom
top 0.75%Web presenceof 133.2M domains by links, Common Crawl
Aug 28, 20252025
News · crowdfundinsider.com
Jun 24, 20252025
News · bioworld.com
Supercede Therapeutics Inc. has released preclinical efficacy data on its small-molecule inhibitor of the Activin receptor type II (ACTRII) to treat obesity. Supercede's lead can…
Sources: the outlets named on each headline, each story once
